TIMP2 and colorectal carcinoma: Wang et al. showed that TIMP2 was a prognostic biomarker in CRC patients, and they confirmed that TIMP2 could directly affect cell invasion, migration, and angiogenesis in CRC patients and play an important role in prognosis.